Ann Surg Oncol (2017) 24:2595 DOI 10.1245/s10434-017-5878-3 OR IGINAL ARTIC L E – COLORECTAL CANCER Total Laparoscopic Management for Stage IV Colorectal Cancer Requiring Multivisceral Resection 1 1 1 1 Y. Nancy You, MD, MHSc , Hironori Shiozaki, MD , Jeffrey E. Lee, MD , Guillaume Passot, MD, MSc , 1 1 1 1 Claire Goumard, MD , Masayuki Okuno, MD, PhD , Thomas A. Aloia, MD , Cathy Eng, MD , George Chang, MD, 1 1 1,2 MS , Jean-Nicolas Vauthey, MD , and Claudius Conrad, MD, PhD 1 2 Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Surgical Oncology, Hepato-Pancreato-Biliary Surgery, Houston, TX ABSTRACT surgery and the second-stage liver resection. Postoperative Background. Surgical resection of all sites of disease, in lengths of stay were 4 and 3 days, respectively, and were combination with effective systemic chemotherapy, offers without complication. Adjuvant FOLFOX was initiated the only potential chance for cure for patients with stage IV 21 days following liver surgery, and the patient has been colorectal cancer (CRC). Coordinated multistage resection disease-free for 36 months. using a minimally invasive approach may provide optimal Conclusion. This case illustrates the feasibility of the total oncologic outcome while potentially offering the beneﬁt of laparoscopic approach to multivisceral resection for syn- decreased morbidity. chronous stage IV CRC in the context of a preplanned, Patient. A 66-year-old women presented with transverse staged multidisciplinary strategy. This approach may offer colon cancer and synchronous metastasis (CRLM) in seg- optimal cancer management, including early return to ment IV involving the middle hepatic vein and main left systemic therapy, shortened time intervals between stages, 1–3 portal pedicle, as well as the left adrenal gland. Due to and minimal postoperative morbidity. favorable response to neoadjuvant chemotherapy (FOL- FOX/bevacizumab), the patient was considered for DISCLOSURE Y. Nancy You, Hironori Shiozaki, Jeffrey E. Lee, resection but developed some obstructive symptoms from Guillaume Passot, Claire Goumard, Masayuki Okuno, Thomas A. the primary tumor, necessitating re-coordination of treat- Aloia, Cathy Eng, George Chang, Jean-Nicolas Vauthey, and Clau- ment sequencing from the ‘liver-ﬁrst’ approach. dius Conrad have declared no conﬂicts of interest. Methods. The ﬁrst procedure combined laparoscopic subtotal colectomy (extracorporeal anastomosis) with left adrenalectomy. After restaging, CRLM was removed sep- REFERENCES arately 2 months later via laparoscopic left hepatectomy 1. Conrad C, Gayet B (eds). Laparoscopic liver, pancreas, and biliary extending beyond the middle hepatic vein. Successful surgery: textbook and illustrated video atlas. Wiley-Blackwell, completion of the two procedures depended on optimal Chichester; 2017. patient/port positioning for the combined colon/adrenal 2. Yamashita S, Sheth RA, Niekamp AS, Aloia TA, Chun YS, Lee JE, et al. Comprehensive complication index predicts cancer- speciﬁc survival after resection of colorectal metastases indepen- dent of RAS mutational status. Ann Surg. Epub 4 Oct 2016. 3. Mise Y, Aloia TA, Brudvik KW, Schwarz L, Vauthey JN, Conrad C. Electronic supplementary material The online version of this Parenchymal-sparing hepatectomy in colorectal liver metastasis article (doi:10.1245/s10434-017-5878-3) contains supplementary improves salvageability and survival. Ann Surg. 2016;263(1):146–52. material, which is available to authorized users. Society of Surgical Oncology 2017 First Received: 21 February 2017; Published Online: 16 May 2017 C. Conrad, MD, PhD e-mail: firstname.lastname@example.org
Annals of Surgical Oncology – Springer Journals
Published: May 16, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera